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Background: Malaria and HIV/AIDS are the two most common infections in sub-Sahara Africa. There are hypotheses
and study reports on the possible association between these two infections, hence the prevalence and outcome of
their co-infection in an endemic population will be important in defining healthcare strategies. A cross sectional
study was carried out at the Holy Family Hospital in Techiman, Ghana, between November 2011 and January 2012,
to determine the prevalence of malaria among HIV sero-positive patients and its impact on hemoglobin levels.
Method: A total of 400 HIV sero-positive participants (292 females and 108 males) aged between 1 and 73 years
were randomly sampled for the study. A questionnaire was administered and 2 ml of venous blood samples were
drawn for malaria parasites detection, CD4 count and haemoglobin level estimations.
Results: Malaria parasites were detected in 47 (11.75%) of the participants. There was no statistically significant
difference between the malaria prevalence rate of females (12.1%) and males (10.2%) P = 0.6047. An overall anaemia
prevalence of 67% was observed. Among participants with malaria the anaemia prevalence was 93.6%. The CD4 cell
count of all the participants ranged between 3 and 1604 cells/μl with a mean of 386.2 (±274.3) cells/μl. Participants
with malaria had CD4 cell count ranged 3 and 512 Cells/μl with the mean being 186.33 (±133.49) Cells/μl. Out of
377 participants (all above 15 years) interviewed on knowledge of malaria transmission and prevention, 87.0% had
knowledge on transmission but only 8.5% use in bed nets.
Conclusion: It was revealed that almost all the patients with malaria infection were anemic.
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Malaria and Human immunodeficiency virus (HIV) infec-
tions are major public health problems in many parts of
the world. Both infections kill millions of people each year
with disproportionate heavy burden on Africa, India,
Southeast Asia and South America [1].
Sub-Saharan Africa harbors 90% of the estimated 219
million cases that results in over 600,000 deaths annually
[2,3]. Severe anemia as a result of malaria occurs in 1.5 to
6.0 million African children annually with mortality rate
of nearly 10%; respiratory distress, hypoglycaemia and
other complications result in an additional 1–2 million* Correspondence: scktaysammy9@yahoo.com
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unless otherwise stated.cases [4]. Malaria is a major cause of maternal anemia,
which in turn is a risk factor for maternal mortality result-
ing in about 35% of preventable cases of low birth weight
[4]. In Ghana malaria is still the leading cause of loss of
days of healthy life [5] as it accounts for at least 20% of
child deaths and over 45% of out-patient attendances [5].
Because of the high prevalence of HIV and malaria in
sub-Saharan Africa, co-infections are common. Recent es-
timates put HIV/AIDS prevalence in Ghana at 2.9% [6]. It
is known that some 225,478 persons are living with the
disease. Further to this, about 12,077 new infections are
recorded annually with corresponding 15, 263 deaths
[6,7]. By 2011, 59,007 people had access to anti-retroviral
treatment; however this represented 57.9% of eligible pa-
tients [6]. Implying that an excess of 40% of people living
with HIV/AIDS are left to die without getting access tois is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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health burden presented by these two infections, their
interaction is still not completely understood [1].
Because of the high prevalence of HIV and malaria in
sub-Saharan Africa, co-infections are common, Because
of the geographic overlap between high-prevalence areas
for malaria and HIV infection, there is growing evidence
that the two infections may synergistically intensify each
other, increasing incidence and complicating treatment ef-
forts [3]. In a region of unstable malaria, HIV infection
had an unexpectedly large association with the outcome
of falciparum malaria where HIV infection was associated
with severe/complicated malaria [8]. Recently Gupta and
Shah using Sensitivity analysis and simulation has shown
that malaria makes people move faster from HIV to AIDS
class and reduce their life span. Radad and coworkers re-
ported that an increase of one log in HIV viral load occurs
during febrile malaria episodes enhancing susceptibility to
malaria in HIV infected patients and this was found to fa-
cilitate the geographic expansion of malaria in areas where
HIV prevalence was high [9].
As the number of malaria and HIV co-infection in-
creased, it has become apparent that anti-retroviral drugs
interact with the few anti-malaria drugs in use, complicat-
ing treatment efforts for both infections [10]. Malaria and
HIV co-infection also result in interactions that adversely
affect the outcome of both conditions, especially among
pregnant women and infants born to HIV infected
mothers [11]. Malaria [12] and HIV [13] individually are
known to cause maternal anemia. Further to this, a num-
ber of researchers have reported a negative effect of the
combined impact of HIV and malaria on maternal
hemoglobin (Hb) concentrations [14]. However, there is a
dearth of information on the collective impact of HIV-
malaria co-infection on the hemoglobin levels in the gen-
eral population. Understanding the impact of HIV and
malaria co-infection therefore, is important for determin-
ing approaches to treatment and prevention.
Methods
The study was conducted in the Holy Family Hospital;
the only facility that provides ART services to HIV pa-
tients in the municipality. It has bed capacity of 167
beds. Patients diagnosed to have HIV/AIDS infection
and who sought treatment at ART clinic at the Holy
Family Hospital were the source population for the study.
The drugs administered for the first line of treatment were
Azidovudine (d4T), Lamivudine (3TC) plus Nevirapine or
Efavirenz. Nelfinavir, Kaletra and Indinavir were occasion-
ally used in combination with nucleoside based reverse
transcriptase inhibitor drugs. The study was cross-sectional
serological survey where HIV sero-positive patients attend-
ing ART Clinic at the hospital were randomly approached
and invited to participate in the study provided they gavetheir consent. The study took place between November
2011 and January 2012.
Sample size was determined using the binomial model
to estimate the confidence interval (CI). The HIV preva-
lence in the area is known to be less than 3% so the mal-
aria prevalence in the area which is higher was used to
estimate the minimum sample size needed to achieve
enough statistical power. Malaria prevalence in the area
had previously been determined by Owusu-Adjei et al. to
be about 60% in all age cohorts [15]. We calculated the
sample size with a 95% CI and precision level of 5%:
no ¼ ZaPq
d2
In the equation below, n is the sample size, z is the
critical value of the standard normal distribution at the
5% level (1.96), p is the estimated malaria prevalence
(0.60), q = 1 – p, and d is the precision level. This is used
for a small population of up to 3,000. The sample size
obtained was 369. A total of 400 HIV sero-positive indi-
viduals who sought care at the ART Clinic of the Holy
Family Hospital in Techiman and were willing to partici-
pate in the study were recruited.
Study area
Techiman, is a major commercial town in the Brong
Ahafo region linking not only most of Ghana’s major cit-
ies, but also the republic of Togo, Burkina Faso and Cote
D’Ivoire. It has an estimated total land area of about
669.7 square kilometers. According to the 2000 popula-
tion and housing census, the population of the munici-
pality was estimated to be 202,409 by December 2005,
with an average growth rate of 3.0% per annum. Agricul-
ture and related trades are the major economic activities
in the municipality. Over half of the economically active
population is engaged in these activities. This makes
Techiman market the largest food crop market in
Ghana. The municipality has twenty four (24) health
care facilities; including two mission hospitals in Techi-
man, (i.e. Holy Family and Ahamadiya Hospitals), nine
government health centers, four private maternity homes
and three private clinics.
Ethical clearance
The study was approved by the Committee on Human
Research Publication and Ethics from Kwame Nkrumah
University of Science Technology and the management
of Holy Family Hospital - Techiman. Consent of partici-
pants was also obtained prior to the study. All consent-
ing patients attending the ART clinic were eligible for
participation except infants less than 6 months. Refusal
of some patients to participate in the study did not inter-
fere with their routine care at the hospital.
Table 1 Socio-economic and demographic characteristics
of patients (participants)





5 -9 2 0.5
10 -14 9 2.3
15 – 24 37 9.3
25 – 34 147 36.8
35- 44 118 29.5







No formal education 151 49.5








Other Skills 30 7.5
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A questionnaire, in both English and Twi (the local
language) which included the basic socio- demographics of
the study subjects as well as their knowledge and preven-
tion of malaria was used. Two independent translators were
engaged, one translated the English to Twi, the other was
who had no prior copy of the English was tasked to trans-
late the local language back into English. This was done to
ensure the consistency of thought. No personal identifiers
were included and individuals were given unique codes on
the questionnaires and their laboratory specimens.
Malaria parasite
Laboratory investigation was conducted using the Thin
Blood Film method. A drop of blood, 3–5 mm in diameter
was put on a slide and spread with the corner of another
slide to form a thin blood smear. The smear was thor-
oughly allowed to dry, fixed with methanol and stained
with Giemsa stain for about 15 minutes. The stained
smear was washed with running tap water, allowed to dry
in air and examined microscopically for the presence of
malaria parasites.
HIV infection
HIV test was conducted using First Response HIV Card
Test 1–2.0 (Premier Medical Corporation Ltd, Mumbai,
India). Reactive blood samples were confirmed with
Oraquick Rapid HIV – ½ Antibody Test (OraSure Tech-
nologies Inc., Bethlehem, USA). Both test kits are
immuno-chromatographic rapid tests for qualitative de-
tection of antibodies specific to HIV in human serum,
plasma or whole blood.
CD4 count and Haemoglobin concentration
The CD4 count of the study population was determined
using Becton-Dickinson FASCount flow cytometer (BD
Biosciences, California, USA) whilst the haemoglobin con-
centration was estimated with Sysmex XT – 2000i Haema-
tology Analyzer (Sysmex Corporation, Hong Kong, China).
Results
Socio-economic and demographic characteristics
A total of 400 HIV sero-positive patients between 1 and
73 years were included in the study. Majority of them
(73%). the mean was between 30 and 34 years old. Most
patients were married (38%). Majority (37.1%) had no
formal education, with only 3% having had some tertiary
education. 49.5% of the participants were unemployed
with a further 30.7% being farmers. Further details are
reported in Table 1.
Hemoglobin level of patients (participants)
Hemoglobin (Hb) concentration levels of the patients
ranged between 6.4 and 15.4 g/dl with majority (18.0%)of patients had Hb levels in the range of 12.-12.9 g/dl.
The mean Hb level of the patients was 10.8 g/dl with
mean (SD) for male and female as 11.5 g/dl (2.26) and
10.56 g/dl (2.22) respectively (Table 1, Figure 1). Per the
definition of anemia by the World Health Organization,
hemoglobin levels < 13.0 g/dl in adult men than < 12.0 g/dl
in adult women, an overall prevalence of 67% (268 out of
400) anemia was observed in this study. Majority of pa-
tients had mild to moderate anemia while severe anemia
was observed in 2.8% of patients. Further details are re-
ported in Figure 1 and Table 2.
CD4 count of patients
All patients studied had a CD4 cell count ranging from 3 –
1604 cells/μl. The mean (SD) of CD4 cell count of the pa-
tients was 386.2 (274.3) cells/μl. Majority of the participants
(34.5%) had CD4 count below 200 cells/μl (this represents
the advanced stage of immuno-suppression). Another
33.3% had CD4 counts above 500cells/μl. The rest of the
Figure 1 Median hemoglobin levels of participants in
different gender.








<200 46 (42.6) 92 (31.5) 138 (34.50)
200-349 23 (21.3) 54(18.5) 77 (19.3)
350-499 12 (11.1) 40 (13.7) 52 (13.0)
≥500 27 (25.0) 106 (36.3) 133(33.3)
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further details of CD4 cell count based on gender differ-
ences are shown in the tables (Table 3).
Malaria parasite prevalence
An overall 11.75% (n = 47) were found to be slide posi-
tive for malaria parasite with ages ranging from 2 years
to 56 years. Malaria positivity was mostly within the age
range of 30–34 years, followed by those in the age
ranges of 25–29 years and 35–39 years. The least in-
fected malaria patients were within the age ranges of 15-
19years and 55–59 years. Out of the 47 participants with
patent parasitemia 36 (76%) of them were females with
only 11 being males (Figure 2).
Malaria co infected participants and hemoglobin levels
All participants who had malaria infection had a mean
(SD) haemoglobin level to be 9.9 g/dl (1.61). The
hemoglobin level ranged was from 6.2 g/dl to 13.2 g/dl.
All the participants with malaria infection were anemic
except for one participant who had 13.2 g/dl. Most of
the study participants with malaria infection (13 out of
47) had hemoglobin level between the ranges of 10.0 g/









6-6.9 2 (1.9) 9 (3.1) 11 (2.75)
7-7.9 7 (6.5) 16 (5.4) 23 (5.75)
8-8.9 8 (7.4) 32 (11.0) 40 (10.0)
9-9.9 (12.75) 7 (6.5) 44 (15.1) 51
10-10.9 (14.50) 12 (11.1) 46 (15.8) 58
11-11.9 (15.75) 14 (13.0) 49 (16.8) 63
12-12.9 (18.00) 21 (19.4) 51 (17.4) 72
13-13.9 (14.00) 23 (21.3) 33 (11.3) 56
14-14.9 (6.25) 13 (12.0) 12 (4.1) 25
15-15.9 1 (0.9) 0 (0.00) 1 (0.25)respect to gender was 90.9% and 94.4% for males and fe-
males respectively. Majority of the subjects with malaria
infection 45 (89.4%) had mild to moderate anemia with
only 4.3% (2 out 47) having severe anemia. Severe
anemia was observed in only females (Figure 3).
Malaria infection and CD4 count
All patients with malaria infection had CD4 cell count
ranging from 3 cells/μl to 512 cells/μl with mean (SD)
CD4 cell count of 186.3 (133.5) cell/ul. Males had a
mean of 209 (198.4) cells/μl and females 178.7 (110.8)
cells/μl. The majority, a whopping 66% of participants
with patent malaria infection had their CD4 cell count
below 200 cells/μl. With respect to gender, 63.6% (7 out
of 11) males infected with malaria infection and 66.7%
(24 out of 36) females infected with malaria infection
had CD4 cell count less than 200 cells/μl. Only one pa-
tient with malaria infection had CD4 cell count greater
than or equal to 500 cells/μl and was observed in only
males. Further details are provided in (Figure 4).
Knowledge of malaria transmission and prevention
Participants above 15 years of age (n = 377) interviewed
on malaria transmission and prevention. 87.0% out of
377 of the participants claimed to have some knowledge
about malaria transmission. Out of the 328 respondents
that claimed to have knowledge about malaria, 216
(65.9%) claimed that malaria could be transmitted from
an infected person to a healthy person and the rest 112Figure 2 Age distribution of patients with malaria infection.
Figure 3 Hemoglobin level HIV patients Co-infected with
malaria stratified according to gender.





Knowledge about malaria (n =377)
Yes 328 (87.0)
No 49 (13.0)
Malaria transmissible? (n = 328)
Yes 216 (65.9)
No 112(34.1)
Means of malaria transmission (n =216)
Mosquito bite 197 (91.2)
Body contact 13 (3.4)
Respiratory route 24 (11.1)
Others 28 (13.0)
Malaria is preventable (n = 328)
Yes 304 (92.7)
No 24 (7.3)
Preventive methods (n =304)
Antimalarial tablets 238 (78.3)
Bed nets 231 (76.0)
Mosquito repellents 196 (64.5)
Environmental sanitation 286 (94.1)
Others 87 (28.6)
Use of bed nets (n = 377)
Yes 32 (8.5)
No 345 (91.5)
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ted from person to person or they had no idea at all.
Among those who claimed that malaria is transmissible
(n = 216), 91.2% (n = 197) reported mosquito bite as a
means of transmission (Table 4). About 92.7% (304) of
study participant who claimed to have knowledge about
malaria reported that malaria is preventable. The most
frequently mentioned method of prevention was envir-
onmental sanitation 286 (94.1%) followed by taking anti-
malarial tablets 238(78.3%), bed nets 231(76.0%) and
mosquito repellent 196 (64.5%). The remaining 87
(28.6%) reported various other methods like traditional
cotton clothes, smoke and good diet. It was however
surprising that with all the knowledge they claim to
have, only 8.5% (n = 32) participants actually used bed
net (Table 5).
Discussion
Accumulating data points to pathological interactions
between HIV and malaria in co infected individuals.
However, the public health consequences of this inter-
action have not been completely deciphered. Abu-Radad
and coworkers in Kenya observed that a temporary one-Figure 4 CD4 count distribution of patients infected with
malaria.log elevation in HIV viral load occurs during febrile mal-
aria episodes; in addition, susceptibility to malaria is en-
hanced in HIV-infected patients [11].
In a one-time cross-sectional serological survey, the
current study sought to determine malaria prevalence
in HIV seropositive individuals; their CD4 count to
identify the various stages of immuno-suppression and
their hemoglobin levels to possibly associate the impact
of the co-infection on the outcome of anemia in the
study participants.
Generally malaria transmission in the forest zone of
Ghana is intense [6,15] with very high parasite prevalence
up to 50% [15,16]. But the overall malaria prevalence inTable 5 CD4 cell count in participants co-infected with
malaria
CD4 Count Frequency Male Female P –value
<200 31 (63.6) 7(63.6) 24 (66.7) 0.014
200-349 10 (21.3) 2(18.2) 8(22.2) 0.235
350-499 5(10.6) 1(9.1) 4(11.1) 0.580
>500 1 (2.1) 1(9.1) 0(0.0) 1.000
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was conducted during the drought months (November-
January) which coincide in Ghana with very low malaria
transmission. However in comparison with similar studies
in the African region, malaria prevalence in this study ap-
pears to be higher. The prevalence of malaria infection
among HIV sero-positive patients in South Africa and
Mozambique were lower [17,18]. But the observed preva-
lence is similar with a study done in Southeastern part of
Nigeria in which the prevalence of malaria as a co-infection
amongst asymptomatic HIV sero positive patients was
11.8% [19]. Malaria is known to cause an increase in transi-
tory viral load while HIV causes more clinical malaria,
higher parasitemia and higher rates of treatment failure in
co-infected patients [11].
Females had relatively higher malaria infection com-
pared with their male counterparts. This may be ex-
plained by their typical lifestyle in the community, where
females tend stay out late during mosquito biting hours
carrying out domestic activities. This has variously been
reported elsewhere. Also, among the various age groups,
it was determined that the age 30–34 years harbored
more parasites than the other age groups. This was also
confirmed with the high cumulative density index. How-
ever, prevalence of malaria infection was high in children
within the age group of 0–4 years in which out of 12 pa-
tients, four patients representing 33.3% had malaria in-
fection. This is consistent with several studies in malaria
endemic Africa [19] where prevalence of malaria infec-
tion in HIV children was high. However some studies
have reported lower prevalence of malaria among non
HIV children less than five years in the Brong-Ahafo re-
gion of Ghana [20].
The mean (SD) CD4 cell count of the patients was
386.2 (274.3). Males and females had CD4 count mean
(SD) of 345.7(270.1) cells/μl and 386.1(276.0) cells/μl re-
spectively. The difference in the mean CD4 count is due
to the fact that HIV infection is detected earlier in fe-
males than their male counterparts. With the introduc-
tion of Prevention of Mother -To- Child Transmission
of HIV (PMTCT) programme, women of child bearing
age are screened for HIV infection during antenatal care
or at obstetrics and gynecology clinics. Those who test
positive are then incorporated into ART clinics while
there is no similar program for males for the early detec-
tion of HIV.
CD4 cell count less than 200 cells/μl (signifying the
terminal stage of HIV infection (AIDS) was seen in
34.5% patients. Obviously the major reason for this high
proportion of AIDS is because of late presentation,
largely due to the fact that we are yet to imbibe the cul-
ture of voluntary screening for early detection and treat-
ment. Fear of stigmatization, lack of awareness and
inadequate trained counseling personnel are some of thefactors militating against voluntary screening. Many pa-
tients only seek medical attention and are diagnosed
when HIV infection becomes complicated by AIDS de-
fining illnesses. Majority of the patients (66.0%) with
malaria infection had CD4 cells count less than 200
cells/μl. This can be attributed to the well establishment
that CD4+ T lymphocyte cells <200 cells/μl is associated
with a higher risk of opportunistic infection and poor
disease progression [16].
Anemia is a frequent complication of infection with
the human immunodeficiency virus, and could be clinic-
ally important. Multifactorial origin of anemia compli-
cates determining its original cause and/or its proper
treatment [21]. Using hemoglobin level of less than
13.0 g/dl and 12.0 g/dl as the cutoff point for anemia in
males and females respectively, the overall prevalence of
anemia among the patients was 67%. The prevalence of
anemia in this study is comparable with other studies
(approximately 70%) [22,23]. The incidence of anemia
was strongly and consistently associated with the pro-
gression of HIV disease as measured by diagnosis of an
AIDS-defining opportunistic illness and measurement of
a CD4 count of 200 cells/μl. This association is most
likely explained by the increasing viral burden as HIV
disease progresses, which could cause anemia by in-
creased cytokine mediated myelosuppression which im-
pair erythropoiesis. Also several opportunistic organisms
like Mycobacterium tuberculosis, Histoplasma, Crypto-
coccus, Coccidiodes, Pneumocystis carinii, and Leish-
mania have been shown to infiltrate the bone marrow
and disrupt erythropoiesis [24]. Alternatively anemia
may be a surrogate marker for some aspect of disease
progression not captured by controlling for CD4 count
and clinical AIDS diagnosis.
Several drugs used to combat HIV and its complications
may contribute to the anemia that is seen in HIV infec-
tion. The administration of Zidovudine is recognized to
cause anemia because of myelo-suppression [25].
Males and females did not show significant difference
in the prevalence of anemia. Different studies have re-
ported increase prevalence of anemia in females than
males which were largely attributed to menstrual blood
loss and to the drains on iron stores that occur with
pregnancy and delivery [21]. However in this study, it
was revealed that most males report to the ART clinic late
by which HIV infection without antiretroviral therapy in
the vast majority of infected males has progressively
destroyed the immune system leading to opportunistic
diseases and other condition that lead to anemia in HIV
infection has advanced.
Majority of the HIV patients with anemia were mild to
moderate anemia with few patients (2.75%) with severe
anemia. This is in agreement with studies by Meidani
and co workers [21] where mild to moderate anemia
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their studies. It was revealed that almost all the patients
with malaria infection were anemic. This may be due to
the clearance and or destruction of infected RBCs, the
clearance of uninfected RBCs, erythropoietic suppression
and dyserythropoiesis as reported as reported by others
elsewhere by [26].
About 87% of the patients who responded to the ques-
tionnaire claimed to have some knowledge on malaria
transmission in their area. This is an indication that the
area selected for the study is malarious and known to have
malaria transmission. More than half (65.9%) of the re-
spondents who claimed to know or have heard of malaria,
reported malaria to be transmissible. The rest (34.1%) re-
ported that malaria cannot be transmitted from infected
person to healthy ones or they have no idea about it at all.
Among those who knew that malaria is transmitted, 91.2%
reported mosquito bite as a means of transmission. These
are encouraging results and show the presence of a better
knowledge in the method of malaria transmission however
despite good knowledge about malaria transmission,
this study also revealed evidence of knowledge gaps
about malaria by some respondents misconception that
that malaria is transmitted through drinking contaminated
water, eating contaminated food, staying in the sun and
working in rain.
Over 92.0% of the patients in this study reported that
malaria is preventable. Over 75% of the patients who re-
ported malaria are preventable stated taking tablets and
use of bednets as methods of malaria prevention how-
ever only 8.5% use bednets. Discomfort, primarily due to
heat, and perceived (low) mosquito density were the
most widely identified reason for non-use of mosquito
net. There were concerns by respondents about higher
prices of mosquito nets to the extent of not being afford-
able by some respondents.
Malaria infection was high in HIV positive patients
with CD4 count less than 200 cells/μl. Mild to moderate
anemia was frequent in HIV positive patients but severe
anemia was not prevalent in the study population. Al-
most all study participants with malaria were found to
be anemic. This confirms the association between mal-
aria and anemia. Future studies should compare preva-
lence of malaria co-infection among HIV/AIDS Sero-
positive individuals and non HIV/AIDS individuals with
malaria.
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